Tissue engineering a pancreatic substitute based on recombinant intestinal endocrine cells
Cell-based treatments for insulin-dependent diabetes (IDD) may provide more physiologic regulation of blood glucose levels than daily insulin injections, thereby reducing the occurrence of secondary complication associated with IDD. An autologous cell source is especially attractive for regulatory a...
| Main Author: | |
|---|---|
| Published: |
Georgia Institute of Technology
2009
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/1853/26627 |